MPL-5821

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMPL-5821
Drug Alias NameMPL-5821
ClassificationSmall molecules
Mechanisms of ActionP38 mitogen-activated protein kinase inhibitors
TargetsP38 mitogen-activated protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChroma Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChroma Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A